Serina Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $2.4M | $10.7M | $6.7M |
| FY2019 | $4.8M | $7.4M | $2.4M |
| FY2020 | $9.3M | $3.9M | $527.0K |
| FY2021 | $15.0M | $3.2M | $584.0K |
| FY2022 | $20.6M | $3.2M | $645.0K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $2.4M | $10.7M | $6.7M |
| FY2019 | $4.8M | $7.4M | $2.4M |
| FY2020 | $9.3M | $3.9M | $527.0K |
| FY2021 | $15.0M | $3.2M | $584.0K |
| FY2022 | $20.6M | $3.2M | $645.0K |